• PRAKHAR NEMA Adina College of Pharmacy, Sagar (M. P.) India
  • AMBIKA CHOURASIYA Adina Institute of Pharmaceutical Sciences, Sagar (M. P.) India
  • AMIT SHUKLA Adina Institute of Pharmaceutical Sciences, Sagar (M. P.) India
  • HARSHNA VISHWAKARMA Adina College of Pharmacy, Sagar (M. P.) India
  • HARSHITA JAIN Adina Institute of Pharmaceutical Sciences, Sagar (M. P.) India
  • PRATEEK KUMAR JAIN Adina College of Pharmacy, Sagar (M. P.) India




Berberis aristata, Signalling, Pharmacognostic study, Berberine, Extract, Phytoconstituent


Indian barberry is a very common plant with miraculous therapeutic activity. This plant was being used from very ancient times. It generally has Habitat of North-western Himalayas, Nilgiris, Kulu, and Kumaon. Propagation of this herb is carried out during the spring season. It is listed in “Ayurveda” for the treatment of various dysenteries. It is well known as “Daruhaldi” in Ayurveda because it is having properties like turmeric. It is also used in different systems of medication like in Ayurveda, Siddha, and Yunani. Twigs are either white or pale yellowish-brown in colour. The bark is having a pale brown appearance on the outside and has deep yellowish colour inside. Leaves are obovate, with reticulated venation, and are arranged in tufts of five to eight. These leaves are having a glossy dark green appearance on the outside and a light green colour inside. Flowers are yellow and are usually bisexual. The fruits are bright red. The stem is subterete, pale brownish yellow. It chiefly contains “berberine” as an active phytoconstituent that belongs to alkaloids. Other than berberine it also contains contain barbamine, oxyberberine, palmatine, and taxilamine. Roots of Berberis aristata contain berberine, barbamine, Jatrorrhizine, columbamine and oxyberberine. This plant is having various therapeutic activities like; antibacterial, antiperiodic, antidiarrheal, antipyretic, antidiabetic, and anticancer activities. Several research works were performed for this plant with the use of systemic animal models. A significant result was obtained. Investigations suggested that it can be used as an antimalarial, antioxidant, anti-inflammatory, hypoglycaemic, and hepatoprotective.


Download data is not yet available.


Komal S, Ranjan B, Neelam C, Birendra S, Kumar SN. Berberis aristata: a review. Int J Res Ayurveda Pharm. 2011;2(2):383-8.

Shah NC, Joshi MC. An ethnobotanical study of the Kumaon region of India. Econ Bot. 1971 Oct 1;25(4):414-22. doi: 10.1007/BF02985209.

Chauhan NS. Medicinal and aromatic plants of Himachal Pradesh. Indus publishing; 1999.

Rathi B, Sahu J, Koul S, Kosha RL. Detailed pharmacognostical studies on Berberis aristata DC plant. Anc Sci Life. 2013 Apr;32(4):234-40. doi: 10.4103/0257-7941.131981, PMID 24991073.

Khare CP. Indian medicinal plants: an illustrated dictionary. Springer Science+Business Media; 2008 Apr 22.

Saran S, Padalia H, Ganeshaiah KN, Oberai K, Singh P, Jha AK. In: Remote Sensing of Northwest Himalayan Ecosystems. Berlin: Springer. 2019. p. 251-64. doi: 10.1007/978-981-13-2128-3_11.

Srivastava SK, Khatoon S, Rawat AK, Mehrotra S, Pushpangadan P. Pharmacognostic evaluation of the root of Berberis aristata DC. Nat Prod Sci. 2001;7(4):102-6.

Akhtar MS, Sajid SM, Akhtar MS, Ahmad M. Hypoglycaemic effect of Berberis aristata roots, aqueous and methanolic extracts in normal and alloxan-diabetic rabbits. Pharmacologyonline. 2008;2:845-56.

Semwal BC, Gupta J, Singh S, Kumar Y, Giri M. Antihyperglycemic activity of root of Berberis aristata DC in alloxan-induced diabetic rats. Int J Green Pharm (IJGP). 2009;3(3). doi: 10.22377/ijgp.v3i3.97.

Ahmad R. Mild antihyperglycaemic activity in Eclipta alba, Berberis aristata, Betula utilis, Cedrus deodara, Myristica fragrans and Terminalia chebula. Indian J Sci Technol. 2008 Oct 1;1(5):1-6. doi: 10.17485/ijst/2008/v1i5.1.

Gupta JK, Mishra P, Rani A, Mazumder PM. Blood glucose lowering potential of stem bark of Berberis aristata DC in alloxan-induced diabetic rats. Iranian Journal of Pharmacology and Therapeutics. 2010 Jan;9(1):21-4.

Semwal BC, Shah K, Chauhan NS, Badhe R, Divakar K. Antidiabetic activity of stem bark of Berberis aristata DC in alloxan induced diabetic rats. Internet J Pharmacol. 2008 Nov;6:1531-76.

Komal S, Ranjan B, Neelam C, Birendra S, Kumar SN. Berberis aristata: a review. Int J Res Ayurveda Pharm. 2011;2(2):383-8.

Gilani AH, Janbaz KH. Preventive and curative effects of Berberis aristata fruit extract on paracetamol-and CCl4-induced hepatotoxicity. Phytother Res. 1995 Nov;9(7):489-94. doi: 10.1002/ptr.2650090705.

Janbaz KH, Gilani AH. Studies on preventive and curative effects of berberine on chemical-induced hepatotoxicity in rodents. Fitoterapia. 2000 Feb 1;71(1):25-33. doi: 10.1016/S0367-326X(99)00098-2, PMID 11449466.

Gilani AH, Janbaz KH, Aziz N, Herzig MJ, Kazmi MM, Choudhary MI. Possible mechanism of selective inotropic activity of the n-butanolic fraction from Berberis aristata fruit. Gen Pharmacol. 1999 Nov 1;33(5):407-14. doi: 10.1016/S0306-3623(99)00035-X, PMID 10553882.

Kumar S. Comparative study of some antimalarials on clearance of blood-stage Plasmodium berghei infection. Animal Model Exp Med. 2018 Sep;1(3):235–41. doi: 10.1002/ame2.12029, PMID: 30891570.

Das S, Das MK, Mazumder PM, Das S, Basu SP. Cytotoxic activity of methanolic extract of Berberis aristata DC on colon cancer. Glob J Pharmacol. 2009 Mar;3(3):137-40.

Mazumder PM, Das S, Das S, Das MK. Cytotoxic activity of methanolic extracts of Berberis aristata DC and Hemidesmus indicus R. Br. MCF7 cell line. J Curr Pharm Res. 2010;15:12.

Anis KV, Rajeshkumar NV, Kuttan R. Inhibition of chemical carcinogenesis by berberine in rats and mice. J Pharm Pharmacol. 2001 May;53(5):763-8. doi: 10.1211/0022357011775901, PMID 11370717.

Singh J, Kakkar P. Antihyperglycemic and antioxidant effect of Berberis aristata root extract and its role in regulating carbohydrate metabolism in diabetic rats. J Ethnopharmacol. 2009 May 4;123(1):22-6. doi: 10.1016/j.jep.2009.02.038, PMID 19429334.

Shahid M, Rahim T, Shahzad A, Latif TA, Fatma T, Rashid M. Ethnobotanical studies on Berberis aristata DC. root extracts. Afr J Biotechnol. 2009;8(4).

Gupta SK, Agarwal R, Srivastava S, Agarwal P, Agrawal SS, Saxena R. The anti-inflammatory effects of Curcuma longa and Berberis aristata in endotoxin-induced uveitis in rabbits. Invest Ophthalmol Vis Sci. 2008 Sep 1;49(9):4036-40. doi: 10.1167/iovs.07-1186, PMID 18421073.

Gacche RN, Dhole NA. Antioxidant and possible anti-inflammatory potential of selected medicinal plants prescribed in the Indian traditional system of medicine. Pharm Biol. 2006 Jan 1;44(5):389-95. doi: 10.1080/13880200600751691.

Sharma RS, Mishra V, Singh R, Seth N, Babu CR. Antifungal activity of some Himalayan medicinal plants and cultivated ornamental species. Fitoterapia. 2008 Dec 1;79(7-8):589-91. doi: 10.1016/j.fitote.2008.06.004, PMID 18672040.

Khanum R, Gilani SA. Conservational status of plant seedlings in Ayubia National Park, Pakistan. Lyonia Online. J Ecol. 2005 Jul;8(1):51-60.

Kulkarni SK, Dhir A. Possible involvement of L-arginine-nitric oxide (NO)-cyclic guanosine monophosphate (cGMP) signaling pathway in the antidepressant activity of berberine chloride. Eur J Pharmacol. 2007 Aug 13;569(1-2):77-83. doi: 10.1016/j.ejphar.2007.05.002, PMID 17585901.

Biswas TK, Mukherjee B. Plant medicines of Indian origin for wound healing activity: a review. Int J Low Extrem Wounds. 2003 Mar;2(1):25-39. doi: 10.1177/1534734603002001006, PMID 15866825.

Tripathi YB, Shukla SD. Berberis aristata inhibits PAF-induced aggregation of rabbit platelets. Phytother Res. 1996 Nov;10(7):628-30. doi: 10.1002/(SICI)1099-1573(199611)10:7<628::AID-PTR913>3.0.CO;2-X.



How to Cite

NEMA, P., A. CHOURASIYA, A. SHUKLA, H. VISHWAKARMA, H. JAIN, and P. K. JAIN. “A PRECISE STUDY ON “BERBERIS ARISTATA”. International Journal of Current Pharmaceutical Research, vol. 14, no. 6, Nov. 2022, pp. 10-16, doi:10.22159/ijcpr.2022v14i6.2057 .



Review Article(s)